Feraccru®
Our lead product, Feraccru®, is a novel oral treatment for iron deficiency anaemia (IDA). Following receipt of marketing authorisation in early 2016, Feraccru® is now commercially available for use initially in patients with inflammatory bowel disease associated IDA.
Read more
